oneplacenews
Source: Ars Technica
Summary
The FDA has approved a second species of carcass-eating fly for use in maggot therapy, a treatment that uses live fly larvae to clean wounds. This approval expands the options for medical professionals in managing wounds effectively.
Why It Matters
This advancement in maggot therapy underscores the growing recognition of biotherapy in modern medicine, particularly for treating chronic wounds. By allowing more fly species, it increases the potential for personalized treatment options, thereby improving patient outcomes and fostering innovations in wound care strategies.
